Your browser is no longer supported. Please, upgrade your browser.
BWAY Brainsway Ltd. monthly Stock Chart
Brainsway Ltd.
Index- P/E- EPS (ttm)-0.65 Insider Own2.89% Shs Outstand11.13M Perf Week6.77%
Market Cap71.98M Forward P/E- EPS next Y-0.26 Insider Trans0.00% Shs Float3.77M Perf Month13.08%
Income- PEG- EPS next Q-0.04 Inst Own18.18% Short Float0.17% Perf Quarter-17.58%
Sales21.28M P/S3.38 EPS this Y74.00% Inst Trans- Short Ratio0.61 Perf Half Y-11.26%
Book/sh1.65 P/B3.92 EPS next Y0.00% ROA- Target Price11.19 Perf Year-28.59%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range5.10 - 12.53 Perf YTD-33.64%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-48.36% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low26.86% ATR0.24
Employees107 Current Ratio- Sales Q/Q1.40% Oper. Margin- RSI (14)61.08 Volatility2.56% 3.41%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.22 Prev Close6.45
ShortableYes LT Debt/Eq- EarningsNov 18 BMO Payout- Avg Volume10.78K Price6.47
Recom1.50 SMA207.41% SMA508.61% SMA200-8.41% Volume13,098 Change0.31%
May-13-19Initiated Raymond James Outperform $14
May-13-19Initiated Oppenheimer Outperform
May-13-19Initiated Ladenburg Thalmann Buy
May-13-19Initiated Cantor Fitzgerald Overweight $17
Nov-18-20 07:00AM  
Nov-17-20 07:00AM  
Nov-11-20 07:00AM  
Nov-04-20 07:00AM  
Nov-02-20 08:00AM  
Oct-13-20 09:00AM  
Oct-06-20 09:00AM  
Sep-08-20 07:00AM  
Sep-03-20 07:26AM  
Sep-02-20 07:00AM  
Aug-26-20 08:37AM  
Aug-25-20 10:21AM  
Aug-24-20 07:00AM  
Aug-12-20 07:24AM  
Jul-29-20 07:00AM  
Jul-21-20 09:00AM  
Jun-24-20 02:09PM  
Jun-16-20 07:30AM  
Jun-09-20 07:30AM  
May-20-20 07:30AM  
May-06-20 07:30AM  
May-04-20 09:00AM  
Apr-13-20 07:30AM  
Apr-07-20 09:00AM  
Mar-23-20 08:00AM  
Mar-11-20 09:00AM  
Mar-04-20 08:16AM  
Feb-20-20 09:00AM  
Feb-10-20 09:00AM  
Feb-06-20 09:39AM  
Feb-04-20 09:00AM  
Jan-21-20 09:00AM  
Jan-16-20 09:00AM  
Dec-02-19 08:27AM  
Nov-25-19 07:00AM  
Nov-14-19 04:01PM  
Nov-12-19 09:00AM  
Oct-29-19 11:00AM  
Oct-16-19 10:00AM  
Oct-01-19 09:00AM  
Sep-24-19 09:00AM  
Sep-19-19 10:10AM  
Sep-12-19 09:00AM  
Sep-10-19 09:00AM  
Aug-26-19 06:30AM  
Aug-14-19 08:00AM  
Aug-07-19 09:00AM  
Jul-25-19 09:00AM  
Jul-18-19 07:00AM  
Jun-27-19 10:01AM  
Jun-24-19 07:00AM  
Jun-17-19 07:00AM  
Jun-13-19 07:00AM  
Jun-05-19 09:00AM  
May-29-19 07:00AM  
May-23-19 07:00AM  
May-22-19 07:00AM  
May-13-19 09:04AM  
May-01-19 09:00AM  
Apr-22-19 04:00PM  
Apr-16-19 08:55PM  
Apr-15-19 04:08PM  
Apr-14-19 09:53AM  
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.